Announced details
Extensive track record in product development and manufacturing (specific figures are not disclosed)
Scheduled to become a subsidiary of the Company through the acquisition of shares and share exchange announced on 29 June 2026.
A company engaged in OEM and ODM manufacturing of health foods and health beverages, offering services from planning and development through to manufacturing and packaging. Other information, including its location, representative, capital and year of establishment, is not disclosed.
From approximately 1,500 bottles (small-batch manufacturing)
The impact is currently expected to be limited, but the initiative is expected to contribute to improved consolidated performance over the medium to long term.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | OEM, ODM and contract manufacturing of health foods and health beverages, D2C/OEM model |
| Counterparty | 株式会社国際漢方研究所 |
| Counterparty overview | A company engaged in OEM and ODM manufacturing of health foods and health beverages, offering services from planning and development through to manufacturing and packaging. Other information, including its location, representative, capital and year of establishment, is not disclosed. |
| Relationship with the Company | Scheduled to become a subsidiary of the Company through the acquisition of shares and share exchange announced on 29 June 2026. |
| Launch date | Not disclosed (scheduled to be established going forward) |
| Applicable area | D2C Business, EC Business, Beauty and health-related products, Food, Sports and fitness, Influencers and creators, Local governments and regional brands, Companies' original brands, promotional products and shareholder benefit products |
| Location scale | From approximately 1,500 bottles (small-batch manufacturing) |
| Usage history | Extensive track record in product development and manufacturing (specific figures are not disclosed) |
| Impact on Business Performance | The impact is currently expected to be limited, but the initiative is expected to contribute to improved consolidated performance over the medium to long term. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To create synergies through post-M&A integration by combining 国際漢方研究所's manufacturing technology and product development capabilities with the Group's marketing and sales capabilities.